Home > Journals > Minerva Urology and Nephrology > Past Issues > Minerva Urology and Nephrology 2022 August;74(4) > Minerva Urology and Nephrology 2022 August;74(4):475-8

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EDITORIAL COMMENT   Free accessfree

Minerva Urology and Nephrology 2022 August;74(4):475-8

DOI: 10.23736/S2724-6051.22.04946-1

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Comment on: “Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications”

Enrico CHECCUCCI 1, 2, 3 , Gabriele VOLPI 2, Sabrina DE CILLIS 2, Federico PIRAMIDE 2, Alberto PIANA 2, Alessandro VECCIA 4, Ugo FALAGARIO 5, Davide LOIZZO 6, 7, Savio D. PANDOLFO 7, 8, Riccardo AUTORINO 7 , Daniele AMPARORE 2

1 Department of Surgery, Candiolo Cancer Institute - FPO-IRCCS, Candiolo, Turin, Italy; 2 Division of Urology, Department of Oncology, University of Turin, Turin, Italy; 3 Uro-technology and SoMe Working Group of the Young Academic Urologists (YAU) Working Party of the European Association of Urology (EAU), Arnhem, the Netherlands; 4 Unit of Urology, ASST Carlo Poma Hospital, Mantua, Italy; 5 Department of Urology and Organ Transplantation, University of Foggia, Foggia, Italy; 6 Unit of Urology, Andrology and Kidney Transplantation, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy; 7 Division of Urology, VCU Health, Richmond, VA, USA; 8 Department of Neurosciences, Sciences of Reproduction, and Odontostomatology, University of Naples Federico II, Naples, Italy



top of page